Table 2 End stage renal disease risk of included studies

Lam et al. 2012 [15]

Nephrol Dial Transplant

2027

20,270

6.9 (median)

6.5 (median)

ESRD: Acute dialysis in follow-up up period (continuous veno-venous or intermittent)

1

14

0.58 (95%CI, 0.08–4.47)

Muzaale et al. 2014 [13]

JAMA

96,217

96,217

7.6 [3.9–11.5]

15.0 [13.7–15.0]

ESRD: Earliest of initiation of maintenance dialysis, placement on the waiting list, receipt of a living or deceased donor kidney transplant

99

36

2.75 (95% CI, 1.96–3.85)

Kim et al. 2019 [16]

Renal Epidemiology

1901

32,621

15.1 [1.5–43.9]

24.9 [0.1–26.0]

CKD: estimated glomerular filtration rate of < 60 ml/min/1.73m2 and/or the presence of proteinuria in two or more consecutive visits

3

2969

Model I

13.63 (95%CI, 4.39–42.26)

Age,

Sex,

Center,

Year of screening exam

Model II

8.63 (95%CI, 2.78–26.84)

 + Baseline eGFR,

Smoking status,

Alcohol intake,

Regular exercise,

Education level,

Hx of DM, HTN,

Medication use of DM,HTN, Dyslipidemia

Model III

8.72 (95%CI, 2.80–27.12)

 + 

Renal compensation hypertrophy

Mjoen et al. 2013 [14]

Kidney International

1901

32,621

15.1 [1.5–43.9]

24.9 [0.1–26.0]

ESRD: initiation of renal replacement therapy (dialysis, transplantation)

9

22

Inclusion year, Age, Sex, sBP, BMI, Smoking

18.99 (95%CI, 8.63–41.76)

11.38 (95%CI, 4.37–29.63)

Glomerulonephritis (3)

Systemic

lupus erythematosus (1)

Wegner's granulomatosis (1)

ANCA-positive vasculitis (1)

Sarcoidosis(1)

DM/Nephrosclerosis (2)

Glomerulonephritis (5)

Pyelonephritis (4)

PCKD (4)

HTN (3)

DM (1)

Amyloidosis (1)

Systemic lupus erythematosus (1)

Drug induced nephropathy (1)

Medullary

cystic disease (1)

Haugen et al. 2020 [17]

Transplantation International

1029

16,084

11.3 (mean)

16.4 (mean)

CKD: eGFR < 60 ml/min

216

236

14.31 (95% CI, 9.71–21.08)